Lunai Bioworks Inc. (NASDAQ: LNAI) announced that its subsidiary BioSymetrics has signed a letter of intent with Geneial Inc. to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE